ArticleBioengineering (Basel, Switzerland)2022
Decision Support System for Liver Lesion Segmentation Based on Advanced Convolutional Neural Network Architectures.
Article in Bioengineering (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Automated deep learning for real-time focal liver lesions detection in ultrasound videos a multicenter study.NPJ digital medicine · 2026Article
- Machine Learning for Biomedical Applications.Bioengineering (Basel, Switzerland) · 2024Article
- How Artificial Intelligence Is Shaping Medical Imaging Technology: A Survey of Innovations and Applications.Bioengineering (Basel, Switzerland) · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Given its essential role in body functions, liver cancer is the third most common cause of death from cancer, despite being the sixth most common type of cancer worldwide. Following advancements in medicine and image processing, medical image segmentation methods are receiving a great deal of attention. As a novelty, the paper proposes an intelligent decision system for segmenting liver and hepatic tumors by integrating four efficient neural networks (ResNet152, ResNeXt101, DenseNet201, and InceptionV3). Images from computed tomography for training, validation, and testing were taken from the public LiTS17 database and preprocessed to better highlight liver tissue and tumors. Global segmentation is done by separately training individual classifiers and the global system of merging individual decisions. For the aforementioned application, classification neural networks have been modified for semantic segmentation. After segmentation based on the neural network system, the images were postprocessed to eliminate artifacts. The segmentation results obtained by the system were better, from the point of view of the Dice coefficient, than those obtained by the individual networks, and comparable with those reported in recent works.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.